FWM
SANA icon

Foguth Wealth Management’s Sana Biotechnology SANA Stock Holding History

Foguth Wealth Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.5K Buy
10,981
+150
+1% +$483 ﹤0.01% 212
2026
Q1 		$35.7K Buy
10,831
+429
+4% +$1.69K ﹤0.01% 210
2025
Q4 		$43.6K Buy
+10,402
New +$46.6K 0.01% 174

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Foguth Wealth Management's SANA Position: Q2 2026 in Review

Foguth Wealth Management increased its Sana Biotechnology (SANA) stake by 1.4% in Q2 2026, buying an estimated $483 and bringing the position to 10,981 shares worth $34.5K. The position accounts for ﹤0.01% of the portfolio, ranked #212.

Foguth Wealth Management first reported a position in SANA in Q4 2025 and has held it in 3 quarters since. The position peaked at $43.6K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Foguth Wealth Management held 10,981 shares of Sana Biotechnology worth $34.5K as of Q2 2026.
  • Foguth Wealth Management bought 150 Sana Biotechnology shares in Q2 2026, an estimated $483.
  • Sana Biotechnology made up ﹤0.01% of Foguth Wealth Management's portfolio in Q2 2026, its #212 holding.
  • Foguth Wealth Management first reported a position in Sana Biotechnology in Q4 2025 and has held it in 3 quarters since.
  • Foguth Wealth Management's Sana Biotechnology position peaked at $43.6K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Foguth Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.